Ondine Biomedical Inc (OBI) NPV

- Add to watchlist
- Create an alert
- This stock can be held in a




14.50p
15.00p
14.50p
£60.97 million
14.50p
13.50p
5.63p
n/a
0.10p (0.69%) Previous:
0.10p
201,513
n/a
20,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 1.20 | 0.64 |
Profit before tax ($m) | (14.41) | (19.37) |
Adjusted EPS (¢): | (7.00) | (10.00) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Ondine Biomedical upbeat on new Steriwave test data
9 June 2025 15:59
-
Ondine's Steriwave adopted by Ottawa Heart Institute
5 June 2025 12:28
-
Ondine appoints Alan Thomas as interim finance chief
9 May 2025 12:50
-
Second Quebec Hospital Adopts Steriwave
19 June 2025 07:00
-
UK Doctor Wins Award for NHS Steriwave Innovation
16 June 2025 07:00
-
NHS Trust up for HSJ Award for Steriwave Use
12 June 2025 07:00
Annual & interim reports
Annual & interim reports are not available for this stock.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.